Dec. 7, 2020
by William Patrick Slattery
Biopharma insight
Artificial Intelligence (A.I.) has revolutionized many industries as we speak, which doesn't exclude pharmaceuticals. However, unlike other sectors concerning Information …
Nov. 29, 2020
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
Oct. 5, 2020
by Amandeep Singh
Biopharma insight
The pharmaceutical business is one of the riskiest industries to venture into. Drug discovery is an artisanal process where a …
Sept. 14, 2020
by Raj Indupuri
Biopharma insight
How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like …
Sept. 5, 2020
by Patrick Bailey
Biopharma insight
In the "data age," an estimated 81% of Americans own at least one smartphone. That might lead one to wonder …
July 22, 2020
by Andrii Buvailo
Interview
While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited …
July 11, 2020
by Andrii Buvailo
Biopharma insight
What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they …
July 8, 2020
by Andrii Buvailo
Biopharma insight
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …
July 2, 2020
by Andrii Buvailo
Interview
Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of …
July 1, 2020
by David Shlaes
Biopharma insight
(This post originally appeared on David Shlaes's personal blog) The US FDA just published an analysis of antibiotic development looking back …
June 19, 2020
by Irina Bilous
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological …
May 22, 2020
by Andrii Buvailo
Interview
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected …